Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo


The Mumbai R&D facility has an experienced team of 28 scientists including 8 Ph.Ds dedicated to innovation in new product development, cost optimization, and novel route scouting projects for generic APIs. The R&D team develops novel/non-infringing process for APIs and is supported by state-of-the-art, best in class, analytical research capabilities.

Location Address:

Piramal Pharma Limited, Plot No R-856,TTC Industrial Area, Rabale MIDC, Off Thane-Belapur Road,  Ghansoli, Navi Mumbai,Thane - 400701 Maharashtra.

Contact: +91 22 6806 8000

Specialized Capabilities:

  • Development of environmental friendly processes
  • Development of chiral APIs
  • Ability to comply with ICH guidelines
  • Synthesis, Isolation and characterization of impurities
  • Expertise in handling pyrophoric reagent
  • Expertise in cryogenic reactions (-40 to -100°C)
  • Expertise in handling organometallic reactions

Generic API business

Our Generic API business partners with pharmaceutical companies across the globe and supplies generic APIs to more than 60 countries across the globe. The site has filed more than 10 APIs and has 2 APIs under development. The APIs developed at this site are then manufactured at manufacturing sites in our network inspected by various regulatory authorities including US FDA, UK MHRA, PMDA Japan, and ANVISA among others. The site boasts of a strong regulatory team with knowledge of filing in various countries/geographies.